 Treatment benign prostatic hypertrophy long-acting gonadotropin-releasing hormone analogue experience Benign prostatic hypertrophy common ailment elderly men surgery androgens prostatic hypertrophy withdrawal logical way condition hormone analogues chemical castration cases benign prostatic hypertrophy experience men monthly injection gonadotropin-releasing hormone prolonged periods men months prostatic volume average initial volume clinical objective improvement men normal flow rates Residual urine volume unaltered patients subjective amelioration objective subjective improvement Maximal decrease prostatic volumes months treatment treatment additional shrinkage months discontinuation treatment prostatic volumes pre-treatment values similar decrease flow rates Symptoms improved periods mode treatment offers majority men benign prostatic hypertrophy Proper patient selection serum prostate specific antigen positive results therapy patients high risk surgical anesthetic intervention